Clinical Trial

Obtain Safety and Effectiveness of CT-ACL001, a Regenerative Ligament Using Biological Tissue, in ACLR

Name: Obtain Safety and Effectiveness of CT-ACL001, a Regenerative Ligament Using Biological Tissue, in ACLR — clinical trial record (NCT07129694)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Enrolling by Invitation

View on ClinicalTrials.gov →

Summary

A randomized, multicenter study comparing the safety and efficacy of CT-ACL001, a regenerative ligament, with standard treatment in anterior cruciate ligament reconstruction

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-08-15.

Trial Details

NCT Number	NCT07129694
Lead Sponsor	CoreTissue BioEngineering Inc. Collaborators: Japan Agency for Medical Research and Development, Mediscience Planning, Inc.
Conditions	Anterior Cruciate Ligament Rupture
Enrollment	64 participants
Start Date	2024-11-25
Primary Completion	2026-11 (estimated)
Study Completion	2027-11 (estimated)
Updated on ClinicalTrials.gov	2025-09-30